Disclosure Of First-Time Adoption [Text Block]

Captor Therapeutics S.A. - Filing #6179999

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
96 322 PLN
175,000 PLN
170 031 PLN
19 785 PLN
94 102 PLN
417,000 PLN
16,000 PLN
96 322 PLN
11 779 PLN
11,000 PLN
124 201 PLN
58 208 PLN
170 031 PLN
413,000 PLN
124 201 PLN
175,000 PLN
58 208 PLN
175,000 PLN
124 201 PLN
11,000 PLN
124 201 PLN
170 031 PLN
11 779 PLN
413,000 PLN
7,000 PLN
359,000 PLN
1 004 PLN
25 636 PLN
5 690 PLN
16 292 PLN
1 004 PLN
2 284 PLN
Comprehensive income
35 889 PLN
35 894 PLN
35 889 PLN
5,000 PLN
38,000 PLN
32 530 PLN
4,000 PLN
32 530 PLN
32 572 PLN
Profit (loss)
35 894 PLN
35 894 PLN
35 894 PLN
32 572 PLN
32 572 PLN
32 572 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.